MARK P COLONNESE Insider Trading $VXRT Vaxart, Inc.
Get free email notifications about insider trading for MARK P COLONNESE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK P COLONNESE. MARK P COLONNESE is CFO and EVP in Aviragen Therapeutics, Inc. ($NABI) and Chief Financial Officer in Aviragen Therapeutics, Inc. ($NABI) and Exec VP Comm Operations & CFO in ATHEROGENICS INC ($AGIX) and Exec VP Commercial Operations in ATHEROGENICS INC ($AGIX) and Exec VP, Commercial Operations in ATHEROGENICS INC ($AGIX) and Sr VP Finance & Admin & CFO in ATHEROGENICS INC ($AGIX) and Sr VP Finance & Admin, CFO in ATHEROGENICS INC ($AGIX) and Sr VP Finance, Admin & CFO in ATHEROGENICS INC ($AGIX) and Sr VP Finance/Admin & CFO in ATHEROGENICS INC ($AGIX) and Sr VP, Finance & Admin, CFO in ATHEROGENICS INC ($AGIX) and Director in BIO-PATH HOLDINGS INC ($BPTH).
MARK P COLONNESE in Vaxart, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of MARK P COLONNESE: CFO and EVP, Chief Financial Officer
Holdings: 7,000 shares
Current Value: $7,980
Latest Transaction: Apr 05 2017
$VXRT Market Capitalization: $43.28M
$VXRT Previous Close: $1.14
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARK P COLONNESE in Vaxart, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIX, BPTH, VXRT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2017 | AVIR | Aviragen Therapeut ... | COLONNESE MARK P | Chief Financial Off ... | Option Exercise | A | 0.66 | 400,000 | 262,400 | 775,000 | |
| Jul 29 2016 | NABI | Aviragen Therapeut ... | COLONNESE MARK P | CFO and EVP | Option Exercise | A | 1.34 | 150,000 | 201,000 | 375,000 | |
| Feb 09 2016 | NABI | Aviragen Therapeut ... | COLONNESE MARK P | Chief Financial Off ... | Buy | P | 1.41 | 6,700 | 9,428 | 7,000 | 300 to 7 K (+2,233.33 %) |
| Feb 09 2016 | NABI | Aviragen Therapeut ... | COLONNESE MARK P | Chief Financial Off ... | Buy | P | 1.40 | 300 | 419 | 300 | 0 to 300 |
| Nov 03 2015 | NABI | Aviragen Therapeut ... | COLONNESE MARK P | Chief Financial Off ... | Option Exercise | A | 2.02 | 225,000 | 454,500 | 225,000 |
Page: 1